nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—NOD pathway—DUOX2—hypothyroidism	0.0491	0.0939	CbGpPWpGaD
Nedocromil—CYSLTR2—cardiovascular system—hypothyroidism	0.0455	0.145	CbGeAlD
Nedocromil—FPR1—blood—hypothyroidism	0.0324	0.103	CbGeAlD
Nedocromil—PTGDR—adrenal gland—hypothyroidism	0.0306	0.0976	CbGeAlD
Nedocromil—PTGDR—blood—hypothyroidism	0.0306	0.0976	CbGeAlD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.0282	0.0539	CbGpPWpGaD
Nedocromil—PTGDR—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.0227	0.0434	CbGpPWpGaD
Nedocromil—FPR1—Peptide GPCRs—TSHR—hypothyroidism	0.0172	0.033	CbGpPWpGaD
Nedocromil—HSP90AA1—adrenal cortex—hypothyroidism	0.0163	0.052	CbGeAlD
Nedocromil—HSP90AA1—heart—hypothyroidism	0.0157	0.0502	CbGeAlD
Nedocromil—HSP90AA1—cardiovascular system—hypothyroidism	0.0148	0.0474	CbGeAlD
Nedocromil—CYSLTR1—adrenal gland—hypothyroidism	0.0135	0.0432	CbGeAlD
Nedocromil—CYSLTR1—blood—hypothyroidism	0.0135	0.0432	CbGeAlD
Nedocromil—HSP90AA1—gonad—hypothyroidism	0.0135	0.043	CbGeAlD
Nedocromil—HSP90AA1—pituitary gland—hypothyroidism	0.0131	0.042	CbGeAlD
Nedocromil—HSP90AA1—adrenal gland—hypothyroidism	0.0117	0.0375	CbGeAlD
Nedocromil—HSP90AA1—blood—hypothyroidism	0.0117	0.0375	CbGeAlD
Nedocromil—Feeling hot—Liotrix—hypothyroidism	0.0114	0.0693	CcSEcCtD
Nedocromil—HSP90AA1—thyroid gland—hypothyroidism	0.0113	0.0362	CbGeAlD
Nedocromil—PTGDR—G alpha (s) signalling events—TSHB—hypothyroidism	0.011	0.0211	CbGpPWpGaD
Nedocromil—PTGDR—G alpha (s) signalling events—TSHR—hypothyroidism	0.011	0.0211	CbGpPWpGaD
Nedocromil—HSP90AA1—female gonad—hypothyroidism	0.011	0.035	CbGeAlD
Nedocromil—HSP90AA1—testis—hypothyroidism	0.00971	0.031	CbGeAlD
Nedocromil—HSP90AA1—liver—hypothyroidism	0.00918	0.0293	CbGeAlD
Nedocromil—FPR1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.0091	0.0174	CbGpPWpGaD
Nedocromil—HSP90AA1—cerebellum—hypothyroidism	0.00897	0.0286	CbGeAlD
Nedocromil—HSP90AA1—VEGFR2 mediated vascular permeability—VAV3—hypothyroidism	0.00866	0.0166	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—SLC5A7—hypothyroidism	0.00707	0.0135	CbGpPWpGaD
Nedocromil—CYSLTR2—G alpha (q) signalling events—TRH—hypothyroidism	0.00699	0.0134	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00697	0.0133	CbGpPWpGaD
Nedocromil—Body temperature increased—Liothyronine—hypothyroidism	0.00697	0.0424	CcSEcCtD
Nedocromil—HSP90AA1—Integrins in angiogenesis—PIK3C2A—hypothyroidism	0.00659	0.0126	CbGpPWpGaD
Nedocromil—PTGDR—G alpha (s) signalling events—AVP—hypothyroidism	0.0065	0.0124	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00625	0.012	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.0061	0.0117	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.0059	0.0113	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00544	0.0104	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00544	0.0104	CbGpPWpGaD
Nedocromil—Bronchitis—Liotrix—hypothyroidism	0.00539	0.0328	CcSEcCtD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.00537	0.0103	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00525	0.0101	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00525	0.0101	CbGpPWpGaD
Nedocromil—Tremor—Levothyroxine—hypothyroidism	0.00497	0.0303	CcSEcCtD
Nedocromil—Tremor—Dextrothyroxine—hypothyroidism	0.00497	0.0303	CcSEcCtD
Nedocromil—HSP90AA1—Regulation of actin dynamics for phagocytic cup formation—VAV3—hypothyroidism	0.0049	0.00938	CbGpPWpGaD
Nedocromil—CYSLTR1—G alpha (q) signalling events—TRH—hypothyroidism	0.00484	0.00927	CbGpPWpGaD
Nedocromil—FPR1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00478	0.00915	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—TRH—hypothyroidism	0.00465	0.0089	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00463	0.00885	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrins in angiogenesis—VAV3—hypothyroidism	0.00452	0.00866	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—TRH—hypothyroidism	0.00449	0.00859	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00433	0.00829	CbGpPWpGaD
Nedocromil—PTGDR—G alpha (s) signalling events—POMC—hypothyroidism	0.00432	0.00826	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—TSHB—hypothyroidism	0.00414	0.00793	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—TSHR—hypothyroidism	0.00414	0.00793	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00412	0.00789	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00412	0.00789	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—TSHB—hypothyroidism	0.004	0.00766	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—TSHR—hypothyroidism	0.004	0.00766	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.00396	0.00758	CbGpPWpGaD
Nedocromil—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00386	0.0235	CcSEcCtD
Nedocromil—Dyspnoea—Levothyroxine—hypothyroidism	0.00386	0.0235	CcSEcCtD
Nedocromil—Dysgeusia—Liotrix—hypothyroidism	0.00382	0.0233	CcSEcCtD
Nedocromil—Fatigue—Dextrothyroxine—hypothyroidism	0.00373	0.0227	CcSEcCtD
Nedocromil—Fatigue—Levothyroxine—hypothyroidism	0.00373	0.0227	CcSEcCtD
Nedocromil—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—VAV3—hypothyroidism	0.0037	0.00708	CbGpPWpGaD
Nedocromil—CYSLTR2—G alpha (q) signalling events—AVP—hypothyroidism	0.00367	0.00702	CbGpPWpGaD
Nedocromil—Tremor—Liotrix—hypothyroidism	0.00366	0.0223	CcSEcCtD
Nedocromil—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00354	0.0216	CcSEcCtD
Nedocromil—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00354	0.0216	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—TRH—hypothyroidism	0.00352	0.00674	CbGpPWpGaD
Nedocromil—Urticaria—Levothyroxine—hypothyroidism	0.00344	0.0209	CcSEcCtD
Nedocromil—Urticaria—Dextrothyroxine—hypothyroidism	0.00344	0.0209	CcSEcCtD
Nedocromil—Body temperature increased—Levothyroxine—hypothyroidism	0.00342	0.0208	CcSEcCtD
Nedocromil—Abdominal pain—Levothyroxine—hypothyroidism	0.00342	0.0208	CcSEcCtD
Nedocromil—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00342	0.0208	CcSEcCtD
Nedocromil—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00342	0.0208	CcSEcCtD
Nedocromil—Chest pain—Liotrix—hypothyroidism	0.00332	0.0202	CcSEcCtD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—VAV3—hypothyroidism	0.00329	0.00629	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00328	0.00628	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00321	0.00614	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00321	0.00614	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Liotrix—hypothyroidism	0.00319	0.0194	CcSEcCtD
Nedocromil—FPR1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00318	0.00608	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—TSHR—hypothyroidism	0.00314	0.00601	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—TSHB—hypothyroidism	0.00314	0.00601	CbGpPWpGaD
Nedocromil—Asthenia—Dextrothyroxine—hypothyroidism	0.00311	0.0189	CcSEcCtD
Nedocromil—Asthenia—Levothyroxine—hypothyroidism	0.00311	0.0189	CcSEcCtD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.0031	0.00593	CbGpPWpGaD
Nedocromil—Diarrhoea—Levothyroxine—hypothyroidism	0.00296	0.018	CcSEcCtD
Nedocromil—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00296	0.018	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.00296	0.00567	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00286	0.00547	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00286	0.00547	CbGpPWpGaD
Nedocromil—Dyspnoea—Liotrix—hypothyroidism	0.00284	0.0173	CcSEcCtD
Nedocromil—HSP90AA1—NRF2 pathway—SLC5A5—hypothyroidism	0.00283	0.00541	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—VAV3—hypothyroidism	0.0028	0.00535	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrins in angiogenesis—IGF1—hypothyroidism	0.00279	0.00533	CbGpPWpGaD
Nedocromil—Vomiting—Dextrothyroxine—hypothyroidism	0.00275	0.0168	CcSEcCtD
Nedocromil—Vomiting—Levothyroxine—hypothyroidism	0.00275	0.0168	CcSEcCtD
Nedocromil—Fatigue—Liotrix—hypothyroidism	0.00275	0.0167	CcSEcCtD
Nedocromil—Rash—Dextrothyroxine—hypothyroidism	0.00273	0.0166	CcSEcCtD
Nedocromil—Rash—Levothyroxine—hypothyroidism	0.00273	0.0166	CcSEcCtD
Nedocromil—Dermatitis—Dextrothyroxine—hypothyroidism	0.00273	0.0166	CcSEcCtD
Nedocromil—Dermatitis—Levothyroxine—hypothyroidism	0.00273	0.0166	CcSEcCtD
Nedocromil—Headache—Dextrothyroxine—hypothyroidism	0.00271	0.0165	CcSEcCtD
Nedocromil—Headache—Levothyroxine—hypothyroidism	0.00271	0.0165	CcSEcCtD
Nedocromil—FPR1—G alpha (i) signalling events—POMC—hypothyroidism	0.00268	0.00513	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—TRH—hypothyroidism	0.00263	0.00503	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Liotrix—hypothyroidism	0.0026	0.0159	CcSEcCtD
Nedocromil—HSP90AA1—Axon guidance—CLTC—hypothyroidism	0.00259	0.00496	CbGpPWpGaD
Nedocromil—Nausea—Dextrothyroxine—hypothyroidism	0.00257	0.0157	CcSEcCtD
Nedocromil—Nausea—Levothyroxine—hypothyroidism	0.00257	0.0157	CcSEcCtD
Nedocromil—CYSLTR1—G alpha (q) signalling events—AVP—hypothyroidism	0.00254	0.00487	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—TRH—hypothyroidism	0.00254	0.00485	CbGpPWpGaD
Nedocromil—Urticaria—Liotrix—hypothyroidism	0.00253	0.0154	CcSEcCtD
Nedocromil—Abdominal pain—Liotrix—hypothyroidism	0.00252	0.0153	CcSEcCtD
Nedocromil—Body temperature increased—Liotrix—hypothyroidism	0.00252	0.0153	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—TRH—hypothyroidism	0.00244	0.00467	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—AVP—hypothyroidism	0.00244	0.00467	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00243	0.00465	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—TRH—hypothyroidism	0.00239	0.00456	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—AVP—hypothyroidism	0.00236	0.00451	CbGpPWpGaD
Nedocromil—Hypersensitivity—Liotrix—hypothyroidism	0.00235	0.0143	CcSEcCtD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.00235	0.00449	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—TSHR—hypothyroidism	0.00234	0.00448	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—TSHB—hypothyroidism	0.00234	0.00448	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—TRH—hypothyroidism	0.0023	0.00441	CbGpPWpGaD
Nedocromil—Asthenia—Liotrix—hypothyroidism	0.00229	0.0139	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00227	0.00435	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—TSHB—hypothyroidism	0.00226	0.00433	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—TSHR—hypothyroidism	0.00226	0.00433	CbGpPWpGaD
Nedocromil—Diarrhoea—Liotrix—hypothyroidism	0.00218	0.0133	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—TSHB—hypothyroidism	0.00218	0.00416	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—TSHR—hypothyroidism	0.00218	0.00416	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—POMC—hypothyroidism	0.00214	0.00409	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00213	0.00408	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—TSHB—hypothyroidism	0.00213	0.00407	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—TSHR—hypothyroidism	0.00213	0.00407	CbGpPWpGaD
Nedocromil—Dizziness—Liotrix—hypothyroidism	0.00211	0.0128	CcSEcCtD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00206	0.00394	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—TSHB—hypothyroidism	0.00205	0.00393	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—TSHR—hypothyroidism	0.00205	0.00393	CbGpPWpGaD
Nedocromil—Vomiting—Liotrix—hypothyroidism	0.00203	0.0123	CcSEcCtD
Nedocromil—Rash—Liotrix—hypothyroidism	0.00201	0.0122	CcSEcCtD
Nedocromil—Dermatitis—Liotrix—hypothyroidism	0.00201	0.0122	CcSEcCtD
Nedocromil—Headache—Liotrix—hypothyroidism	0.002	0.0121	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—TRH—hypothyroidism	0.00199	0.00381	CbGpPWpGaD
Nedocromil—Nausea—Liotrix—hypothyroidism	0.00189	0.0115	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—AVP—hypothyroidism	0.00185	0.00354	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CLTC—hypothyroidism	0.00185	0.00354	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—TRH—hypothyroidism	0.00181	0.00346	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—TSHB—hypothyroidism	0.00177	0.0034	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—TSHR—hypothyroidism	0.00177	0.0034	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00168	0.00322	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CLTC—hypothyroidism	0.00163	0.00312	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—POMC—hypothyroidism	0.00162	0.00311	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00161	0.00309	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—TSHB—hypothyroidism	0.00161	0.00308	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—TSHR—hypothyroidism	0.00161	0.00308	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CLTC—hypothyroidism	0.00157	0.00301	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—POMC—hypothyroidism	0.00157	0.003	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—IYD—hypothyroidism	0.00153	0.00293	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—VAV3—hypothyroidism	0.00143	0.00274	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TRH—hypothyroidism	0.00141	0.0027	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—VAV3—hypothyroidism	0.00138	0.00265	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—TRH—hypothyroidism	0.00138	0.00264	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AVP—hypothyroidism	0.00138	0.00264	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TRH—hypothyroidism	0.00136	0.0026	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AVP—hypothyroidism	0.00133	0.00255	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ATP5O—hypothyroidism	0.0013	0.00249	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—VAV3—hypothyroidism	0.0013	0.00249	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—AVP—hypothyroidism	0.00128	0.00245	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—VAV3—hypothyroidism	0.00126	0.0024	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TSHB—hypothyroidism	0.00126	0.0024	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TSHR—hypothyroidism	0.00126	0.0024	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—TRH—hypothyroidism	0.00125	0.0024	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AVP—hypothyroidism	0.00125	0.0024	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CLTC—hypothyroidism	0.00124	0.00236	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—TSHR—hypothyroidism	0.00123	0.00235	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—TSHB—hypothyroidism	0.00123	0.00235	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—POMC—hypothyroidism	0.00123	0.00235	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TPO—hypothyroidism	0.00122	0.00234	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—VAV3—hypothyroidism	0.00122	0.00234	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TSHB—hypothyroidism	0.00121	0.00232	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TSHR—hypothyroidism	0.00121	0.00232	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AVP—hypothyroidism	0.00121	0.00232	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SH2B3—hypothyroidism	0.00112	0.00214	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00112	0.00214	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—TSHB—hypothyroidism	0.00112	0.00214	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—TSHR—hypothyroidism	0.00112	0.00214	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—VAV3—hypothyroidism	0.00109	0.00208	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SH2B3—hypothyroidism	0.00108	0.00207	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TRH—hypothyroidism	0.00107	0.00204	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AVP—hypothyroidism	0.00105	0.002	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—VAV3—hypothyroidism	0.000986	0.00189	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TSHB—hypothyroidism	0.000952	0.00182	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TSHR—hypothyroidism	0.000952	0.00182	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CLTC—hypothyroidism	0.000951	0.00182	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AVP—hypothyroidism	0.00095	0.00182	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—POMC—hypothyroidism	0.000917	0.00175	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—POMC—hypothyroidism	0.000886	0.00169	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VAV3—hypothyroidism	0.000871	0.00167	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CLTC—hypothyroidism	0.000857	0.00164	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—POMC—hypothyroidism	0.000852	0.00163	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SH2B3—hypothyroidism	0.000848	0.00162	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—POMC—hypothyroidism	0.000833	0.00159	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PRL—hypothyroidism	0.000831	0.00159	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—POMC—hypothyroidism	0.000804	0.00154	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PRL—hypothyroidism	0.000802	0.00153	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—VAV3—hypothyroidism	0.000769	0.00147	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VAV3—hypothyroidism	0.000768	0.00147	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—VAV3—hypothyroidism	0.000752	0.00144	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VAV3—hypothyroidism	0.000742	0.00142	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TRH—hypothyroidism	0.00074	0.00142	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AVP—hypothyroidism	0.00074	0.00142	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AVP—hypothyroidism	0.000725	0.00139	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AVP—hypothyroidism	0.000715	0.00137	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—POMC—hypothyroidism	0.000695	0.00133	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—VAV3—hypothyroidism	0.000683	0.00131	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TSHB—hypothyroidism	0.00066	0.00126	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TSHR—hypothyroidism	0.00066	0.00126	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AVP—hypothyroidism	0.000658	0.00126	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—POMC—hypothyroidism	0.000631	0.00121	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PRL—hypothyroidism	0.000629	0.0012	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CLTC—hypothyroidism	0.000615	0.00118	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SH2B3—hypothyroidism	0.000588	0.00113	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VAV3—hypothyroidism	0.000582	0.00111	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TSHB—hypothyroidism	0.000566	0.00108	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AVP—hypothyroidism	0.000561	0.00107	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TRH—hypothyroidism	0.000531	0.00102	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3C2A—hypothyroidism	0.000505	0.000966	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—POMC—hypothyroidism	0.000492	0.000941	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PRL—hypothyroidism	0.000484	0.000927	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—POMC—hypothyroidism	0.000482	0.000922	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—POMC—hypothyroidism	0.000475	0.000909	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TSHB—hypothyroidism	0.000474	0.000906	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TSHR—hypothyroidism	0.000474	0.000906	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IGF1—hypothyroidism	0.000473	0.000905	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IGF1—hypothyroidism	0.000457	0.000875	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—VAV3—hypothyroidism	0.000448	0.000857	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PRL—hypothyroidism	0.000447	0.000856	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—POMC—hypothyroidism	0.000437	0.000837	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PRL—hypothyroidism	0.000436	0.000835	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SLC5A5—hypothyroidism	0.000424	0.000811	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SH2B3—hypothyroidism	0.000422	0.000808	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VAV3—hypothyroidism	0.000404	0.000772	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AVP—hypothyroidism	0.000389	0.000744	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—POMC—hypothyroidism	0.000373	0.000713	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF1—hypothyroidism	0.000359	0.000686	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRL—hypothyroidism	0.000313	0.000599	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VAV3—hypothyroidism	0.00029	0.000554	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AVP—hypothyroidism	0.000279	0.000534	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—POMC—hypothyroidism	0.000258	0.000494	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF1—hypothyroidism	0.000249	0.000476	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—POMC—hypothyroidism	0.000222	0.000424	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—POMC—hypothyroidism	0.000185	0.000355	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF1—hypothyroidism	0.000178	0.000341	CbGpPWpGaD
